Georgios Eleftheriou

Title: Georgios Eleftheriou: Advancing Mental Health Risk Prediction

Introduction

Georgios Eleftheriou is an inventor based in San Francisco, California. His patent work includes a method for predicting the risk of relapse or onset of a psychiatric condition by analyzing speech and biosignals.

Latest Patents

Eleftheriou is associated with 1 patent, titled “Method for Predicting Risk of Relapse or Onset of a Psychiatric Condition.” The method records a user reciting a story designed to elicit an emotion associated with a psychiatric condition while simultaneously capturing the user’s biosignals. It identifies psychophysiological markers that connect emotional responses with those signals, then correlates the markers with clinical assessments to build a predictive model. The model can analyze a user’s biosignals, estimate the risk of condition onset, and trigger a notification if that risk exceeds a specified threshold.

Career Highlights

Eleftheriou works at IQVIA Inc., a company focused on health information and technology. His patent reflects an approach to mental health monitoring that combines speech, physiological data, and clinical assessment to support risk prediction.

Collaborations

The patent lists Panagiotis Fatouros and Charalampos Tsirmpas among Eleftheriou’s coworkers.

Conclusion

Georgios Eleftheriou’s patented method brings together emotional speech, biosignals, and clinical data to help predict psychiatric risk and provide timely notifications.